| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Eric A. Md Rose | Director | $6.49M | Jun 15, 2021 | ||
| Daniel J. Luckshire | Executive VP & CFO | $2.18M | Jul 1, 2024 | ||
| Diem Nguyen | Chief Executive Officer, Director | $2.15M | Oct 25, 2024 | ||
| Thomas E. Constance | Director | $1.99M | Jun 15, 2021 | ||
| Joseph W. Marshall III | Director | $1.85M | Jun 11, 2024 | ||
| Dennis E. Hruby | EVP & Chief Scientific Officer | $1.52M | Jul 1, 2024 | ||
| James Antal | Director | $798K | Jun 14, 2022 | ||
| Jaymie A. Durnan | Director | $619K | Jun 11, 2024 | ||
| Michael C. Plansky | Director | $550K | Jun 14, 2022 | ||
| Larry R. Miller | General Counsel | $510K | Mar 25, 2024 | ||
| Holly L. Phillips | Director | $492K | Jun 11, 2024 | ||
| Julian Nemirovsky | Director | $492K | Jun 11, 2024 | ||
| Gary J. Nabel | Director | $492K | Jun 11, 2024 | ||
| Julie Kane | Director | $383K | Jun 14, 2022 | ||
| Robin E. Abrams | General Counsel and CAO | $302K | Jul 31, 2021 | ||
| Harold Ford | Director | $286K | Jun 11, 2024 | ||
| Evan A. Knisely | Director | $286K | Jun 11, 2024 | ||
| Jay Varma | EVP & Chief Medical Officer, Director | $136K | Jun 11, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|